Ningbo Scientz Biotechnology920685.BJValuation Analysis
Based on the blended 10-year P/E and P/B percentiles, the stock currently sits in the “Fair Value Range” zone.
As of Oct 19, 2026, Ningbo Scientz Biotechnology (920685.BJ) trades at a P/E of 27.60x, P/B of 1.88x, P/S of 6.27x, and a dividend yield of 1.10%.
Longitudinal percentile comparison: P/E sits at the 51st percentile over the trailing 10Y window (vs. 44th percentile over 3Y); P/B sits at the 34th percentile over the trailing 10Y window (vs. 38th percentile over 3Y); P/S sits at the 35th percentile over the trailing 10Y window (vs. 28th percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 46th percentile within its industry and the 38th percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 1.10%, ranking at the 29th percentile over the trailing 20Y window.
The P/E and P/B percentiles diverge here, differing by 16.3 points — relying on either metric alone could be misleading. Its P/E percentile is roughly the same whether measured against the industry or the broader market. Shareholder returns here are driven almost entirely by cash dividends, with minimal contribution from buybacks. Ningbo Scientz Biotechnology operates in the — sector. Data refreshes weekly and is for reference only, not investment advice.
Want the full picture on whether Ningbo Scientz Biotechnology (920685.BJ) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E, P/B, P/S, Dividend Yield & Total Shareholder Yield percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | Market Percentile | Industry Percentile | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | 27.60 | ||||||
| P/B (MRQ) | 1.88 | ||||||
| P/S (TTM) | 6.27 | ||||||
| Dividend Yield | 1.10% | ||||||
| Buyback + Div Yield | 1.10% |